In summary, the present study primarily evaluated the clinical significance of five proteins, including Bcl-2, Bcl-xL, survivin, p21 and cyclin D1, in a cohort of ESCC patients, by correlating their expression of these proteins with various clinical and pathological parameters. Here, BCL2L1 is linked to esophageal squamous cell carcinoma.